Product/Composition:- | Pirfenidone |
---|---|
Strength:- | 267 mg , 801 mg |
Form:- | Tablet |
Reference Brands:- | Esbriet®(US & EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Pirfenidone is an oral antifibrotic medication used to treat idiopathic pulmonary fibrosis (IPF). It slows lung scarring, improves lung function, and reduces inflammation. Marketed as Esbriet in the US and EU, it’s taken three times daily. Common side effects include nausea, rash, and liver enzyme changes.
Pirfenidone is an FDA- and EMA-approved oral antifibrotic drug used to treat idiopathic pulmonary fibrosis (IPF)—a chronic lung disease marked by progressive scarring of lung tissue. Marketed under the brand name Esbriet, pirfenidone helps slow lung function decline, reduce inflammation, and limit fibrosis by inhibiting pro-fibrotic cytokines like TGF-β. Available in 267 mg and 801 mg tablet strengths, it is usually taken three times daily with food. Pirfenidone improves quality of life and delays disease progression in IPF patients. Common side effects include nausea, rash, and photosensitivity. Regular liver monitoring is advised during treatment.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications